A new biomarker in lung cancer

After screening for transactivated genes in non-small cell lung cancer (NSCLC) tissue samples, researchers at the University of Tokyo have identified chondrolectin as a potential lung cancer biomarker. In vitro studies suggested a strong association with shorter survival and a link with cancer cell growth and invasive activity. This could be useful as a diagnostic or prognostic biomarker, and as a potential target for drug development. Abstract

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.